Exchange: NASDAQ
Industry: Biotechnology
Last Trade: 4:00 PM ET 2/9/2012
Last 10 Quotes:
What's This?
Find a Broker »
- li>
- li>
- li>
- li>
- li>
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 0.85 | 0.31 | 174.19 |
| EPS, GAAP | 0.47 | 0.31 | 51.61 |
| Consensus Estimate | 0.72 | -0.12 | NA |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 0.99 | -0.31 | NA |
| EPS, GAAP | 0.53 | -1.02 | NA |
| Consensus Estimate | 1.19 | NA | NA |
| ACOR | Industry Average | |
| P/E (TTM) | 49.83 | 86.30 |
| P/E (Forward) | 77.68 | -4.30 |
| PEG Ratio | 3.61 | -0.21 |
| Price/Sales | 3.70 | 4.64 |
| Beta | 0.46 | 0.80 |
| 2/3/2012 | The Good Leads (WSJ.com) |
| 1/9/2012 | Stocks to Watch: Idenix, Inhibitex and More (WSJ.com) |
![[sm0212smart]](http://s.wsj.net/public/resources/images/PF-AB863_sm0212_C_20120118122431.jpg)
![[smfineprint]](http://s.wsj.net/public/resources/images/PF-AB821_smfine_C_20120111122044.jpg)
![[sm0212funds]](http://s.wsj.net/public/resources/images/PF-AB839_sm0212_C_20120113140400.jpg)
![[sm0212ten]](http://s.wsj.net/public/resources/images/PF-AB840_sm0212_C_20120117120334.jpg)